The findings of clinical studies have indicated that FABP3, which is expressed in mature neurons, colocalizes with αSyn aggregates in the brains of PD and MSA patients, although not with amyloid β or phospho-tau aggregates in the brains of individuals suffering from Alzheimer’s disease (AD) [8]. This evidence concerns the gene FABP3 and Parkinson disease.